Author:
Wiklund Tom A.,Blomqvist Carl P.,Virolainen Martti,Elomaa Inkeri
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference24 articles.
1. Antman KH, Ryan L, Elias A, Sherman D, Grier HE (1989) Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol 7:126
2. Blomqvist C, Wiklund T, Miettinen M, Elomaa I (1990) Low activity of alternating chemotherapy regimen (ifosfamide-etoposide +epirubicin-DTIC) in advanced soft tissue sarcoma (abstract). Ann Oncol 1 [Suppl]:97
3. Blum RH (1975) An overview of studies with Adriamycin (NSC-123127) in the United States. Cancer Chemother Rep 6:247
4. Bodey GP, Rodriguez V, Murphy WK, Burgess A, Benjamin RS (1981) Protected environment-prophylactic antibiotic program for malignant sarcomas: randomized trial during remission induction chemotherapy. Cancer 47:2422
5. Borden EC, Amato DA, Rosenbaum C, Enterline HT, Shiraki MJ, Creech RH, Lerner HJ, Carbone PP (1987) Randomized comparison of three Adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol 5:840
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献